Trevi Therapeutics Inc (NASDAQ:TRVI)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TRVI

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TRVI

  • Market Cap$63.480m
  • SymbolNASDAQ:TRVI
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS89532M1018

Company Profile

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.

Latest TRVI news

Currently there for this company. Visit our news hub for other news .